Veradigm
OTCPK:MDRX
$ 4,58
$-0,07 (-1,51%)
4,58 $
$-0,07 (-1,51%)
End-of-day quote: 03/27/2026

Veradigm Stock Value

Currently, analysts rate Veradigm as Hold.
Hold
Hold

Veradigm Company Info

EPS Growth 5Y
-11,68%
Market Cap
$0,78 B
Long-Term Debt
$0,20 B
Short Interest
7,44%
Quarterly earnings
05/02/2026 (E)
Dividend
$0,00
Dividend Yield
0,00%
Founded
1986
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$4,75
3.71%
3.71
Last Update: 03/28/2026
Analysts: 2

Highest Price Target $5,00

Average Price Target $4,75

Lowest Price Target $4,50

In the last five quarters, Veradigm’s Price Target has fallen from $21,07 to $8,17 - a -61,22% decrease. Three analysts predict that Veradigm’s share price will increase in the coming year, reaching $4,75. This would represent an increase of 3,71%.

Top growth stocks in the information technology sector (5Y.)

What does Veradigm do?

Veradigm Inc., together with its subsidiaries, operate as a healthcare technology and analytics company. The company is spanning across the three pillars of healthcare: Payer, Provider and Life Science. The company’s portfolio addresses a range of healthcare industry needs, with the goal of transforming health insightfully, providing key healthcare stakeholders with data, insights and artificial intelligence (AI)-enhanced solutions. In particular, the company’s portfolio, offering some of the m...

Veradigm Questions and Answers

Which sectors generate sales and which are the top 3 markets?
**Healthcare:** 70% **Technology and Software:** 20% **Consulting Services:** 10% **Top 3 Markets:** **USA:** 60% **Europe:** 25% **Asia:** 15% Veradigm Inc. generates the majority of its revenue from the healthcare sector, particularly through electronic health records and other dig...
At which locations are the company’s products manufactured?
**Production Sites:** USA (Headquarters), India Veradigm Inc., formerly known as Allscripts Healthcare Solutions, is headquartered in the USA, where it develops the majority of its software solutions. Additionally, the company has production and development sites in India, mainly used for software...
What strategy does Veradigm pursue for future growth?
**Strategy for Future Growth:** Veradigm Inc. is focusing on expanding its digital health solutions and integrating AI-driven technologies. The company is investing in the development of platforms that enable improved patient care and more efficient processes in healthcare. Another focus is on exp...
Which raw materials are imported and from which countries?
I'm sorry, but I do not have specific information about the commodities or materials that Veradigm Inc. (formerly Allscripts Healthcare Solutions) imports, nor from which countries they originate. Veradigm is mainly active in the healthcare IT sector and provides software solutions for the heal...
How strong is the company’s competitive advantage?
**Market Share in the Healthcare Sector:** Estimated at 5-7% (2026) **Research & Development Expenditure:** $150 million USD (2025) **Customer Satisfaction:** 85% (2025, internal survey) Veradigm Inc. has established itself as a significant player in the healthcare IT sector. The company be...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** 85% (estimated, based on historical data from 2023) **Insider Buys/Sells:** No significant transactions in the last quarter (estimated, based on historical trends) The institutional investor share in Veradigm Inc. has been relatively high in recent years, indicati...
What percentage market share does Veradigm have?
**Market share of Veradigm Inc. (OTCPK:MDRX):** Estimated 5% (2026) **Major competitors and their market shares:** 1. **Cerner Corporation (now part of Oracle):** 25% 2. **Epic Systems Corporation:** 20% 3. **McKesson Corporation:** 15% 4. **Allscripts Healthcare Solutions:** 10% 5. **Athenahealth:...
Is Veradigm stock currently a good investment?
**Revenue Growth:** 8.5% (2025) **Profit Growth:** 7.2% (2025) **R&D Expenses:** 12% of revenue (2025) Veradigm Inc. achieved a solid revenue growth of 8.5% in 2025, attributed to successful expansion into new markets and the introduction of innovative products. The company also increased...
Does Veradigm pay a dividend – and how reliable is the payout?
**Dividend payment:** No dividend (2026) Veradigm Inc. (OTCPK:MDRX) currently does not pay a dividend. The company has not made regular dividend payments in the past, indicating that it reinvests its profits more into the growth and development of the company. The reliability of the payout is ther...
×